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Objectives: Fatigue is typically associated with multiple sclerosis (MS), but recent studies
suggest that it is also a problem for patients with stroke. While a direct comparison
of fatigue in, e.g., Stroke and MS is desirable, it is presently not easily possible
because of different definitions and assessment tools used for the two conditions. In
the present study, we therefore assessed fatigue in Stroke and MS using a generic, not
disease-specific instrument to allow transdiagnostic comparison.
Method: A total of 137 patients with MS and 102 patients with chronic stroke completed
the SF-36, a generic questionnaire assessing health related quality of life. Fatigue was
measured through the vitality scale of the SF-36. The vitality scale consists of two positive
items (“lot of energy,” “full of life”) and two negative ones (“worn out,” “tired”). The two
negative ones were scaled in reverse order. The vitality scale has been recommended as
reciprocal index of fatigue.
Results: Normalized vitality scores in MS (35.3) and stroke (42.1) were clearly lower than
published reference values from the SF-36 in age-matched healthy controls. The sum
score of the vitality items was lower in MS than in stroke patients. This difference could
not be explained by age, gender, or the Physical Functioning Scale of the SF-36. Both
patient groups showed no positive correlation between fatigue and physical functioning.
Fatigue – as determined with the vitality scale of the SF-36 – correlated with the estimated
working capacity in MS patients, but not in stroke patients.
Conclusion: These findings confirm high fatigue in MS and stroke patients with
higher values in MS. Fatigue has a higher impact on working capacity in MS than in
stroke. Fatigue in both patient groups is not a direct consequent of physical function-
ing/impairment. Vitality score of the SF-36 is a suitable transdiagnostic measure for the
assessment of fatigue in stroke and MS.
Keywords: assessment, fatigue, multiple sclerosis, questionnaire, SF-36, stroke, vitality
Introduction
Fatigue is a prominent and frequent symptom in multiple sclerosis (MS), and affects 60–90% of
patients (1, 2). Fatigue is often experienced as the most disabling and limiting symptom, and greatly
contributes to the degradation of general well-being, quality of life, and social participation (3,
4). Moreover, the impact of fatigue in the workplace can be severe and frequently triggers early
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retirement, even in the early phase of the disease (5). In contrast
to the importance of fatigue for patients, treatment options are
limited and efficacy varies substantively across patients (6) (see
also Khan et al., this special issue). Understanding and distin-
guishing different pathophysiological mechanismsmight improve
individually tailored treatment options.
While fatigue is most prominent in MS, it is also observed
in other conditions. This is particularly for patients with Stroke,
where fatigue has been identified as “a major yet neglected issue”
(7). This perspective has spearheaded more research in this arena
(8–10), but the characteristics of fatigue in stroke have yet to be
fully determined. It is further unclear to what extent fatigue inMS
and Stroke share similarities in their impact on the individual, and
whether fatigue is equally prevalent in the two conditions.
Because fatigue is by far best characterized in MS, bench-
marking fatigue characteristics of other conditions against MS is
important. However, such comparisons are challenging because
themajority of assessment instruments, such as the Fatigue Sever-
ity Scale (11) and the Fatigue Scale for Motor and Cognitive
Functions (FSMC) (12), have been specifically developed for MS,
and might therefore not be equally sensitive in other neurolog-
ical conditions. Moreover, a recent review on fatigue measures
in neurological conditions concluded that the FSMC and the
Unidimensional Fatigue Impact Scale (13, 14) are best suited for
measuring fatigue in MS, while the Profile of Mood States Fatigue
subscale (POMS-F) is the optimal measure for stroke (15).
If fatigue characteristics and fatigue prevalence are to be com-
pared across neurological conditions, it is necessary to use a
generic, disease-unspecific measure, which allows the transdiag-
nostic comparison of fatigue prevalence. Such a generic measure
has been derived from the vitality subscale of the short form SF-
36 (15). The SF-36 is a well-validated and accepted measure of
health, which is used in a wide range of health care settings and
research (16). Its vitality subscale has already been used to assess
fatigue in patients with myocardial infarction (17). The present
study therefore used the vitality subscale to contrast fatigue in 137
MS and 102 Stroke patients. Based on the prevailing notion that
the fatigue affects themajority ofMS patients, we predicted amore
severe manifestation and a higher impact on working capacity in
MS compared to Stroke.
Materials and Methods
Participants
Data from 137 patients with MS (aged 47.3 8.8, 51 males) and
102 patients with chronic stroke (aged 54.3 12.0, 58 males),
admitted to the hospital between January 2011 and March 2012,
were included in the study. The datawere retrospectively extracted
from the database of the Kliniken Schmieder Konstanz, a spe-
cialized inpatient rehabilitation center in southern Germany.
Kliniken Schmieder provides care for a wide range of neuro-
logical conditions but the largest patient groups comprise MS
(800 patients per year), subacute, and chronic stroke (about 300
stroke patients per year). Patients typically stay in the clinic for
3–6weeks. At the beginning of the stay, every patient completes
the SF-36, a health related, generic questionnaire (16). All partici-
pants had a Barthel Index of>70 (qualifying for “Phase D” in the
German rehabilitation system), and were able to independently
exercise personal care.
For MS, the inclusion criteria comprised the confirmed diag-
nosis of MS, based on the McDonald criteria (18), for 12months
or longer. No further selection criteria were employed. The inclu-
sion criteria for stroke encompassed hemorraghic or ischemic
stroke which had occurred at least 12months prior to testing.
Transient ischemic attack (TIA) was not accepted as inclusion
criterion. For both groups, exclusion criteria included (1) other
neurological disorders such as head trauma, M. Parkinson, brain
tumor, neuromuscular disorder, (2) history of psychiatric disor-
ders, (3) major depression, and (4) cancer. In order to evaluate
and compare the degree of impairment in both patient groups,
the Physical Functioning Scale of the SF-36 and the participants’
retirement/employment and insurance status (for details, see next
paragraph) were analyzed.
Assessment
The SF-36 [German translation, version 1, (16)] was applied to all
patients within 2 days of admittance to Kliniken Schmieder. The
SF-36 is a psychometrically well-characterized (19) and widely
used questionnaire to assess functional health and well-being. It
contains 36 questions, which cover the following eight domains:
vitality, physical functioning, bodily pain, general health percep-
tions, role physical functioning, role emotional, social function-
ing, and mental health. Scores on each item range from 0 to 100,
with higher scores reflecting better functioning.
Fatigue was measured through the scores of the vitality domain
(items 9a: “Did you feel full of life,” 9e: “Did you have a lot of
energy,” 9g: “Did you feel worn out,” and 9i: “Did you feel tired”).
These items are rated on a six-step Likert scale, and assigned val-
ues between 1 and 6. Because items 9a and 9e are positively scored,
the respective raw scores were reversed prior to the transfor-
mation into standardized scores [transformed score= 100 (raw
value minimal value)/range]. The average vitality (VT) score was
calculated as the mean standardized scores of the VT items 9a, e,
g, and i.
The level of physical disability was measured through the
Physical Functioning Scale of the SF-36. This scale comprises 10
items (3a:vigorous activities, 3b: moderate activities, 3c: lift, carry
groceries, 3d: climb several flights, 3e: climb one flight, 3f: bend,
kneel, 3g: walk a mile, 3h: walk several blocks, 3i: walk one block,
3j: grooming and bathing). Responses are categorized according
to the following options on a three-step Likert scale (1= strongly
impaired, 2=moderately impaired, and 3= not at all impaired),
and transformed into standard scores ranging from 0 to 100 as
described above.
Unfortunately at the time of admittance, we did not apply a
standardized stroke scale for our patients like theNIHStroke Scale
or the Modified Ranking Scale (mRS) to describe characteristics
of our patient population. But even if we had done so, it would
have been difficult to compare these characteristics toMSpatients,
which aremeasured or scaled with different tools, most often with
the Expanded Disability Status Scale (EDSS, see below).
In order to compare the handicap in both patient groups, the
categorization of their working capacity assessment was taken
from the discharge letters. In agreement with the work capacity
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classification system of German pension funds, the capacity for
full time is defined as6 h a day and part time as 3 to<6 h a day.
A working capacity of <3 h a day corresponds to retirement. The
working capacity is amedical prognostic judgment of the degree to
which patients will be able to work after finishing sick leave. This
judgment is independent of the actual employment status (i.e., all
potentially eligible patients receive this judgment whether they
are in employment or not). This categorization is not developed
as a research tool, but is well standardized and affords excellent
socioeconomic validity. It is also not specific for one diagnostic
group, but allows for transdiagnostic comparison of restrictions
in the working field.
The party covering the cost of the rehabilitation (pension funds
in case of preserved working capacity and health insurance com-
pany in case of retirement) was determined. The working capacity
measure is used uniformly across the range of health conditions
and therefore provides a comparable real-world index of the
capacity to work in both groups. Vitality and Physical Functioning
were calculated for eachworking capacity category for both groups
(Table 3).
The EDSS is documented in patients withMS. EDSS represents
a common scale to quantify disability inMSpatients, ranging from
0 to 10. Zero means no symptoms, 10 means dead due to MS. It
is commonly used in clinical studies to characterize MS patients,
and was therefore included in this study. The measure, however,
is not meaningful to apply in patients with stroke, and is therefore
reported for MS only.
Statistics
Statistical analysis was conducted with SPSS version 19. Nor-
mal distribution of the variables was investigated using the Kol-
mogoroff–Smirnov test. Homogenous distribution of variances
was confirmed by the Levene-test. Independent t-test was used
to determine differences between vitality scores in stroke and
MS patients. An ANOVA was calculated to look for interaction
between diagnostic group and fatigue. A Pearson correlation was
performed to analyze the correlation between fatigue and physical
functioning. An ANCOVA was applied to investigate whether the
difference between both patient groups was independent of age,
sex, and physical functioning.
Results
Patients
The final sample comprised 102 patients with chronic stroke
(mean age 54.3 12.0 years) and 137 patients with MS (mean age
47.3 8.8 years). Age was significantly different in both groups
(t[177]= 5.02; p= 0.0005; η2= 0.096). The gender balance in
the two patient groups was different with 62.8% females in theMS
group and 43.1% in the stroke group (χ2 [1]= 9.1; p= 0.003). In
addition, scores on the Physical Functioning subscale of the SF-36
indicated significantly greater levels of disability in the MS group
(17.8 5.0) than in the stroke group (20.1 5.6; t[183]= 3.2,
p= 0.002). The EDSS – a scale developed for MS patients and
not applicable in stroke patients – indicated a score of 4 reflect-
ing moderate disability (3 refers to the border between light
and moderate disability, 6 means depended on a walking aid to
walk 100m without rest). Although great care was taken only to
include chronic stroke patients, time since onset of symptoms was
longer in MS patients (15.5 years 9.3) than in stroke patients
(5.2 years 6.0) due to its natural and chronic course.
Analysis of the employment status revealed that 70% of MS
patients were funded by the pension fund compared to 76.5% in
the stroke group (Table 1). These are the patients still working
and those still under consideration for returning to work by the
pension fund. At the time of discharge, almost 50% in both groups
(46% of MS and 50% of stroke patients) were categorized as
qualifying for a full time job. Almost 40% of the MS patients fell
in the category for part-time work compared to 25% of stroke
patients. In the stroke group, more patients had reached the status
of being unable to work (25%) compared to theMS patients (14%)
(Table 1).
Fatigue Score
Mean values on the normalized vitality subscale of the SF-36
were 35.4 12.1 in MS patients and 42.1 12.7 in stroke patients
(compare Table 2). These means are well below the vitality data
available through the German Health Survey 1998 (20).
TABLE 1 | Demographics and patients’ characteristics.
Patients
with MS
Patients
with stroke
Sign.
level
N 137 102
Female 63% 43% <0.05
Mean age (range) 47.3 (20–69) 54.3 (21–80) <0.05
Mean EDSS (SD) 4.1 (1.6) Not applicable
Range 0–8
Years since onset, mean (SD) 15.5 (9.3) 5.2 (6.0); 1–33.6 <0.05
Range 1–49
Party paying the rehabilitation
Pension fund (%) 70 76.5
Health insurance company (%) 30 23.5
Estimated working capacity
>6 h 46.2% 50.8%
3–6 h 39.5% 24.6%
<3 h 14.3% 24.6%
Physical Functioning Scale from
SF-36 (SD)
17.8 (5.0) 20.1 (5.6) <0.05
EDSS, Expanded Disability Status Scale.
Paying party: as long as the pension fund pays for rehabilitation, the client is still in the
category of being or becoming potentially able to work. “Estimated working capacity”
displays the number of full-time (>6 h) and part-time (3–6 h) workers as well as the number
of those being unable to work anymore. The paying party and the estimated working
capacity indicate that disability in both groups was similar.
TABLE 2 | Normalized Vitality scores of the vitality subscale of the SF-36
from the present investigation compared to normal values from the German
Health Survey 1998 (20).
Patients/reference
group
Mean SD Comment
Original publication
MS 35.4 12.1 Present data
Stroke 42.1 12.7 Present data
Male, age 40–49 64.2 16.3 German Health Survey 1998 (20)
(N= 6964 participants, age 18–80)
Male, age 50–59 61.5 18.1 German Health Survey 1998 (20)
Female, age 40–49 57.4 18.8 German Health Survey 1998 (20)
Female, age 50–59 57.7 18.8 German Health Survey 1998 (20)
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TABLE 3 | Vitality and Physical Functioning in relation to working capacity in MS and stroke patients.
Estimated working capacity Vitality 10-item Physical Functioning
N Mean (SD; range) Median N Mean (SD; range) Median
Patients with MS
>6 h 43 38.2 (15.8; 5–75) 40 41 52.1 (26.1; 5–100) 50
3–6 h 36 32.8 (21.3; 0–80) 30 33 30.8 (26.9; 0–100) 35
<3 h 13 25.0 (10.0; 5–40) 25 11 30.0 (13.2; 5–45) 35
Patients with stroke
>6 h 32 44.8 (18.4; 15–85) 42.5 32 64.2 (24.1; 15–100) 67.5
3–6 h 15 31.7 (13.2; 10–60) 30 14 56.8 (23.7; 20–95) 60
<3 h 16 41.6 (22.4; 0–80) 40 16 37.2 (31.0; 0–100) 30
Vitality appears to be proportional to working capacity in MS, but not in stroke patients. Working capacity had been estimated from the medical doctor at the time of discharge only in
those patients, whose rehabilitation had been paid from the pension funds (92 patients with MS, 62 patients with stroke).
Statistical analysis of the vitality scores further suggested a
highly significant groupdifference (F= 7.49; p= 0.007), reflecting
higher levels of fatigue in MS than Stroke. This group differ-
ence remained when age, sex, and Physical Functioning were
factored in as covariates (F[1,236]= 4.59; p= 0.033; η2= 0.02 for
age; F[1,236]= 5.96; p= 0.015; η2= 0.03 for sex; F[1,213]= 9.19;
p= 0.003; η2= 0.04 for Physical Functioning). Both groups did
not show positive correlations between fatigue and physical func-
tioning as determined by question three of the SF-36 (Pearson
correlation).
Separate calculation of the vitality scores for each category
of estimated working capacity further revealed that vitality was
closely related to working capacity in MS patients (r= 0.25;
p= 0.02; Pearson correlation), but not in stroke patients. By con-
trast, Physical Functioning is associated to the estimated working
capacity in stroke patients but not in MS patients. These data are
summarized in Table 3.
Discussion
The present study used the vitality score derived from the SF-36 as
an index of fatigue. The data shows that the vitality scores derived
in patients with MS and stroke are lower than normal values of
population based studies. This suggests that patients with stroke
and patients with MS suffer greater fatigue than their healthy
peers. The data further suggests that fatigue is a substantive issue
in both patient groups.
This study allows for a direct comparison between the SF-36
vitality score as a proxy for fatigue in stroke and MS patients.
The SF-36 is a widely evaluated generic patient-assessed health
outcomemeasure (21). The generic character of the questionnaire
enables transdiagnostic comparison of patients with different con-
ditions. In the present study, the comparison was conducted for
fatigue and showed that fatigue in stroke patients falls within a
similar range as in MS patients. This is an important finding since
fatigue, recognized as a major issue in clinical practice, is much
less recognized in patients with stroke.
However, fatigue in MS patients is still higher than in stroke
patients. This might have been expected at least from health
professionals and cares dealing with MS patients.
It appears remarkable to us that there is an association of fatigue
and working capacity in MS patients, but that there is not such
an association in stroke patients. In our view, this confirms the
clinical impression that fatigue has a high clinical impact on MS
patients, but less so in stroke patients. In other words: the close
association of fatigue with working capacity in MS patients sug-
gests that fatigue directly affects working capacity in MS patients.
This is not the case in stroke patients; here, working capacity is
more related to Physical Functioning.
The data confirm that fatigue is more prominent in MS than
stroke. This is a very important finding; since to our knowledge,
only few publications have investigated fatigue in MS and stroke
patients using the same assessment tool. Naess et al. obtained the
Nottingham Health Profile in 191 ischemic stroke patients and
compared it to 337 MS patients (22). It was concluded that stroke
patients often report pain and problems with sleepiness, while MS
patients often report more problems with fatigue. Using alertness
as a marker of fatigue in MS and stroke patients, Claros-Salinas
et al. (23) demonstrated an increase in reaction time during the
course of the day, highlighting the similarity between these two
patient groups.At the same time, the decline of performance inMS
patients appeared slightly greater than in stroke suggesting more
pronounced fatigue inMS patients compared to stroke patients. In
contrast, no decline was found for agematched controls. Mills and
colleagues further developed a new fatigue index for MS patients
(24), and validated the instrument for assessment of fatigue in
stroke patients (25). They concluded that “post-stroke fatigue
appeared to be qualitatively similar to that of MS fatigue, includ-
ing, for example, features associated with physical and cognitive
aspects” (25). The present study therefore provides further evi-
dence that fatigue is an important symptom in the chronic phase of
stroke. Whether the pathophysiological mechanisms underlying
fatigue in stroke andMS are similar or not, however, it needs to be
determined in future research.
Importantly, neither patient group showed a positive associ-
ation between the vitality subscale and the Physical Function
subscale. It is remarkable that the degree of fatigue reported here
cannot be explained by a simple effect of limitations in physical
functioning. Our results suggest that fatigue is not a consequence
of the accumulation of tissue damage. This is in line with recent
observations showing that the Motricity index as well as the
Stroke Impact Scale are not predictive of fatigue (9). Similarly,
structural computer tomography variables (atrophy, white matter
lesions, or previous vascular lesions) were not associated with
fatigue at 1month (26). Previous investigations could not confirm
a significant correlation between EDSS and fatigue (27, 28). This
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stands in contrast to other studies reporting a correlation between
fatigability and motor (“pyramidal”) involvement and disability
(29, 30). While it may be plausible that patients have more fatigue
in the advanced stage, there seems to be no close correlation
between physical impairment and fatigue. Our data confirm that
fatigue is not a direct consequence of physical impairment in MS
or stroke.
Study Limitations
While the use of a general health questionnaire has the advantage
of being applicable in two different patient groups, it has the
obvious disadvantage that it is not a precise instrument, which
can capture fatigue in all its facets. In other words, the benefit of
comparability comes at the cost of accuracy with which fatigue
is assessed. Although stroke and MS patients rated their vitality
in a similar range, confronting patients with a more elaborate
questionnaire or measuring reaction time as a surrogate marker
of fatigue before and after a cognitive challenging task (31) might
provoke different results and might show larger discrepancies
between stroke and MS patients. Although fatigue falls in a sim-
ilar range in both entities, in our opinion the question remains,
whether or not fatigue in stroke patients is as disabling as in
MS patients. We assume that the vitality score is not elaborate
enough to capture the complete phenomenon of fatigue and to
compare the disabling impact of fatigue in both diseases. Never-
theless, the SF-36 is widely applied, easy to handle, and allows for
transdiagnostic comparison between different patient groups.
Another limitation might be the selection of ourMS and stroke
patients. We did not include severely affected stroke patients, who
require further assistance in daily activities. Neither didwe include
stroke patients with a very good prognosis, who do not require
any rehabilitation. The present findings might therefore not be
generalizable to the whole range of longer term outcome present
in stroke survivors.
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